miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma

Yunchuan Sun1, Jianyong Zhao1, Xiaoming Yin1

  • 1Department of Radiation and Chemotherapy, Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, Hebei, 061000, China.

Cell Proliferation
|August 25, 2016
PubMed
Abstract

Insights

MicroRNA-297 (miR-297) is upregulated in lung adenocarcinoma, promoting cancer cell growth and invasion. It targets Glypican-5 (GPC5), suggesting miR-297 acts as an oncogene in this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key regulators in cancer development.
  • The specific role of miR-297 in lung adenocarcinoma remains largely unknown.

Purpose of the Study:

  • To investigate the function and mechanism of miR-297 in lung adenocarcinoma.
  • To identify the target genes of miR-297 in this cancer type.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to measure miR-297 and GPC5 expression.
  • Cell proliferation and colony formation assays (MTT, colony analysis).
  • Luciferase assays, Western blotting to confirm direct targeting of GPC5 by miR-297.

Main Results:

  • miR-297 expression was significantly higher in lung adenocarcinoma tissues and cell lines.
  • Overexpression of miR-297 increased lung adenocarcinoma cell proliferation, migration, and invasion.
  • Glypican-5 (GPC5) was identified as a direct target of miR-297 and was downregulated in tumors.

Conclusions:

  • miR-297 functions as an oncogenic miRNA in lung adenocarcinoma.
  • miR-297 promotes cancer progression, partly through the downregulation of its target gene GPC5.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K